# Osteoporosis Treatment Protocol in Patients With Fragility Fractures: Application and Efficacy

> **NCT04861142** · — · UNKNOWN · sponsor: **University General Hospital of Heraklion** · enrollment: 350 (estimated)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Anti-osteoporotic medication( alendronate or denosumab)

## Key facts

- **NCT ID:** NCT04861142
- **Lead sponsor:** University General Hospital of Heraklion
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-23
- **Primary completion:** 2024-05
- **Final completion:** 2024-10
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2021-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04861142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04861142, "Osteoporosis Treatment Protocol in Patients With Fragility Fractures: Application and Efficacy". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04861142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*